Moyamoya disease: A human model for chronic hypoperfusion and intervention in Alzheimer's disease
Abstract Introduction Chronic cerebral hypoperfusion has been considered the etiology for sporadic Alzheimer's disease (AD). However, no valid clinical evidence exists due to the similar risk factors between cerebrovascular disease and AD. Methods We used moyamoya disease (MMD) as a model of ch...
Main Authors: | Xiang Zou, Yifan Yuan, Yujun Liao, Conglin Jiang, Fan Zhao, Ding Ding, Yuxiang Gu, Liang Chen, Ying‐Hua Chu, Yi‐Cheng Hsu, Patrick Alexander Liebig, Bin Xu, Ying Mao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
Subjects: | |
Online Access: | https://doi.org/10.1002/trc2.12285 |
Similar Items
-
Cognitive dysfunction in Moyamoya disease: latest developments and future directions
by: Xilong Wang, et al.
Published: (2024-12-01) -
Risk factors for early seizure after revascularization in patients with moyamoya disease
by: Hongchuan Niu, et al.
Published: (2022-12-01) -
Moyamoya Disease: Treatment and Outcomes
by: Tackeun Kim, et al.
Published: (2016-01-01) -
Clinical and Radiological Outcomes After Revascularization of Hemorrhagic Moyamoya Disease
by: Kaijiang Kang, et al.
Published: (2020-05-01) -
Moyamoya disease and paranoid schizophrenia: Causality or casualty
by: S. Llunell-Paz, et al.
Published: (2023-04-01)